GALLIUM CITRATE GA-67 (MALLINCKRODT NUCLEAR MEDICINE LLC)
Welcome to the PulseAid listing for the GALLIUM CITRATE GA-67 drug offered from MALLINCKRODT NUCLEAR MEDICINE LLC. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | MALLINCKRODT NUCLEAR MEDICINE LLC |
NON-PROPRIETARY NAME: | gallium citrate ga-67 |
SUBSTANCE NAME: | GALLIUM CHLORIDE GA-67 |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2008-02-21 |
END MARKETING DATE: | 0000-00-00 |
GALLIUM CITRATE GA-67 HUMAN PRESCRIPTION DRUG Details:
Item Description | GALLIUM CITRATE GA-67 from MALLINCKRODT NUCLEAR MEDICINE LLC |
LABELER NAME: | MALLINCKRODT NUCLEAR MEDICINE LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2(mCi/mL) |
START MARKETING DATE: | 2008-02-21 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69945-180_75bc49b1-a7ef-4937-b5ec-180d4e9fc954 |
PRODUCT NDC: | 69945-180 |
APPLICATION NUMBER: | NDA018058 |
Other GALLIUM CHLORIDE GA-67 Pharmaceutical Manufacturers / Labelers: